Vol 1, No 5 (2009)

Mol Cell Pharmacol

Table of Contents

PharmSights

Compound-Induced Block of Ion Channel Pore Function: Inward-Rectifier Potassium Channels as a Model Abstract PDF
Kazuharu Furutani, Hiroshi Hibino, Atsushi Inanobe, Yoshihisa Kurachi 234-244
Endothelin-1, an Endogenous Irreversible Agonist in Search of an Allosteric Inhibitor Abstract PDF
Jo G.R. De Mey, Matthijs G. Compeer, Merlijn J. Meens 246-257
Estrogen’s Place in the Family of Synaptic Modulators Abstract PDF
Enikö A. Kramár, Lulu Y. Chen, Christopher S. Rex, Christine M. Gall, Gary Lynch 258-262
A Potential Preclinical Migraine Model: CGRP-Sensitized Mice Abstract PDF
Andrew F. Russo, Adisa Kuburas, Eric A. Kaiser, Ann C. Raddant, Ana Recober 264-270
Integrins and Oncogenes: Partners in Crime Abstract PDF
Jordi Carreras Puigvert, Louise von Stechow, Bob van de Water, Erik HJ Danen 272-277

Research Articles

The Role of PTHrP in Mitogenic Signaling via EGFR-Dependent Pathways in Breast Cancer Cells Abstract PDF
Majed S. Alokail 278-289

Reviews

The Role of Gadd45a in Suppression of Autoimmunity Abstract PDF
Heiko Johnen, Jesús M. Salvador 290-298

FDA Corner

FDA Approves Kalbitor for Treating Potentially Life-Threatening Attacks of Hereditary Angioedema Abstract PDF
  300
FDA Approves Lysteda to Treat Heavy Menstrual Bleeding Abstract PDF
  300
FDA Approves New Treatment for Chronic Lymphocytic Leukemia Abstract PDF
  301



LumiText Publishing, P.O. Box 774, Ellicott City, MD 21041 

Copyright © 2008 LumiText Publishing. All rights reserved.